SummerHaven Investment Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Hold
57,765
0.78% 17
2026
Q1
$1.24M Sell
57,765
-5,075
-8% -$106K 0.76% 25
2025
Q4
$1.34M Hold
62,840
0.76% 12
2025
Q3
$1.05M Sell
62,840
-50,640
-45% -$759K 0.61% 28
2025
Q2
$1.63M Buy
113,480
+1,153
+1% +$15.8K 1.07% 4
2025
Q1
$1.63M Buy
112,327
+1,028
+0.9% +$14.6K 1.14% 1
2024
Q4
$1.46M Hold
111,299
0.9% 3
2024
Q3
$1.29M Buy
111,299
+55,348
+99% +$522K 0.79% 2
2024
Q2
$422K Buy
55,951
+2,069
+4% +$17.1K 0.28% 170
2024
Q1
$540K Buy
53,882
+982
+2% +$9.14K 0.34% 169
2023
Q4
$492K Buy
52,900
+1,208
+2% +$12.5K 0.32% 182
2023
Q3
$657K Buy
+51,692
New +$709K 0.48% 113
2021
Q3
Sell
-24,280
Closed -$732K 264
2021
Q2
$732K Buy
24,280
+589
+2% +$17.4K 0.42% 131
2021
Q1
$603K Hold
23,691
0.37% 163
2020
Q4
$581K Buy
+23,691
New +$445K 0.45% 128

Other funds holding MD

SummerHaven Investment Management's MD Position: Q2 2026 in Review

SummerHaven Investment Management held its Pediatrix Medical (MD) position steady in Q2 2026 at 57,765 shares worth $1.46M. The position accounts for 0.78% of the portfolio, ranked #17.

SummerHaven Investment Management first reported a position in MD in Q4 2020 and has held it in 15 quarters since. The position peaked at $1.63M in Q2 2025. 305 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • SummerHaven Investment Management held 57,765 shares of Pediatrix Medical worth $1.46M as of Q2 2026.
  • SummerHaven Investment Management left its Pediatrix Medical share count unchanged in Q2 2026.
  • Pediatrix Medical made up 0.78% of SummerHaven Investment Management's portfolio in Q2 2026, its #17 holding.
  • SummerHaven Investment Management first reported a position in Pediatrix Medical in Q4 2020 and has held it in 15 quarters since.
  • SummerHaven Investment Management's Pediatrix Medical position peaked at $1.63M in Q2 2025.
  • 305 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on SummerHaven Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.